Patients with symptoms of heart failure, depending on the severity of symptoms and cause, received loop diuretics, MRA (mineralocorticoid receptor antagonists), antiarrhythmics, nitrates, antitrombotics, and different supportive therapies. This evidence concerns the gene NR3C2 and heart failure.